Antigenic peptide compound
US4578219A · kind A · utility
2Cited by
3References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 1984 |
| Grant date | Mar 25, 1986 |
| Priority date | — |
| Expiry date | Oct 19, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/806
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The novel antigenic linear peptide of this invention comprise a linear peptide of 13 amino acids, comprising the sequence Val-Asn-Met-Thr-Ala-Gly-Glu-Glu-Gly-Leu-Leu-Lys-Lys. This compound corresponds with the amino acids 304 to 316 of mouse LDH-C.sub.4. The compound has utility in vaccines for reducing the fertility of female mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.